Pluribus Labs’s NVIDIA NVDA Stock Holding History

Pluribus Labs’s Portfolio NVDA Stock Details NVDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.12M	Buy	73,700 +36,560	+98%	+$690K	2.04%	9
2022 Q1	$1.01M	Buy	37,140 +8,750	+31%	+$219K	4.03%	6
2021 Q4	$835K	Buy	+28,390	New	+$781K	0.88%	11

Other funds holding NVDA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Pluribus Labs's NVDA Position: Q2 2022 in Review

Pluribus Labs increased its NVIDIA (NVDA) stake by 98% in Q2 2022, buying an estimated $690K and bringing the position to 73,700 shares worth $1.12M. The position accounts for 2.04% of the portfolio, ranked #9.

Pluribus Labs first reported a position in NVDA in Q4 2021 and has held it in 3 quarters since. 2,825 funds tracked by Wall St. Rank hold NVDA as of Q2 2022.

Pluribus Labs held 73,700 shares of NVIDIA worth $1.12M as of Q2 2022.
Pluribus Labs bought 36,560 NVIDIA shares in Q2 2022, an estimated $690K.
NVIDIA made up 2.04% of Pluribus Labs's portfolio in Q2 2022, its #9 holding.
Pluribus Labs first reported a position in NVIDIA in Q4 2021 and has held it in 3 quarters since.
2,825 funds tracked by Wall St. Rank held NVIDIA as of Q2 2022.

Based on Pluribus Labs's 13F filing for Q2 2022, filed 12 Aug 2022.